The prevalence of diabetes is on the rise in Canada, and there has been a corresponding increase in the rate of micro- and macrovascular complications. Among the worst of these is chronic kidney disease (CKD). It may be diagnosed either through the detection of persistent albuminuria or an estimated glomerular filtration rate that is persistently less than 60 mL/min/1.73 m2. Patients with diabetes and CKD have a lower quality of life and higher health care costs, and face the prospect of end-stage renal disease requiring dialysis. More importantly, this group has an extremely elevated cardiovascular risk and correspondingly reduced survival. Research over several decades has led to two important conclusions. First, progressive worsening of kidney disease is not inevitable in people with diabetes; it can be slowed or even stopped. Second, the elevated cardiovascular risk in this population can be significantly reduced through an aggressive approach to cardiovascular risk factor reduction. These conclusions have prompted Canadian guideline groups, such as the Canadian Diabetes Association and the Canadian Hypertension Education Program, to release clinical practice guidelines that address the management of people with diabetes and CKD. In the present article, the studies that have influenced these Canadian guidelines are examined, and areas in which further research is still required are identified.
Notes
Cites: J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S250-417130270
Cites: Lancet. 2007 Mar 3;369(9563):750-617336651
Cites: Ann Intern Med. 1993 Apr 15;118(8):577-818452322
Cites: Fam Pract. 1993 Jun;10(2):169-728359606
Cites: Lancet. 1998 Jun 13;351(9118):1755-629635947
Cites: BMJ. 1998 Sep 12;317(7160):703-139732337
Cites: Lancet. 1998 Oct 17;352(9136):1252-69788454
Cites: J Am Soc Nephrol. 1998 Dec;9(12):2336-439848788
Cites: Kidney Int. 2000 Sep;58(3):1228-3710972685
Cites: Am J Kidney Dis. 2000 Sep;36(3):646-6110977801
Cites: Ann Intern Med. 2001 Mar 6;134(5):370-911242497
Cites: JAMA. 2001 Jun 6;285(21):2719-2811386927
Cites: Med Decis Making. 2001 Jul-Aug;21(4):288-9411475385
Cites: Kidney Int. 2001 Sep;60(3):1131-4011532109
Cites: N Engl J Med. 2001 Sep 20;345(12):851-6011565517
Cites: N Engl J Med. 2001 Sep 20;345(12):861-911565518
Cites: N Engl J Med. 2001 Sep 20;345(12):870-811565519
Cites: Am J Kidney Dis. 2001 May;37(5):890-911325669
Cites: Kidney Int. 2002 Mar;61(3):1086-9711849464
Cites: Int Ophthalmol. 2001;24(1):1-1111998880
Cites: Am J Kidney Dis. 2002 Sep;40(3):611-2212200814
Cites: Kidney Int. 2002 Dec;62(6):2216-2212427148
Cites: Lancet. 2003 Jan 11;361(9352):117-2412531578
Cites: N Engl J Med. 2003 Jan 30;348(5):383-9312556541
Cites: J Am Soc Nephrol. 2003 Jun;14 Suppl 1:S36-4112761237
Cites: Kidney Int. 2003 Sep;64(3):1004-1112911550
Cites: Am J Kidney Dis. 2003 Dec;42(6 Suppl 5):A5-7, S1-23014655179